AI Enabled Content Generation for Clinical and Regulatory Documents
What is the current state of AI in clinical and regulatory content? In Part One of our three-part series, we assessed your organization’s AI readiness for automating regulatory and clinical trial document creation. In Part Two, we explored Structured Content Authoring, defining this essential building block to establish modular frameworks representing all the data associated with clinical […]
AI in Drug Repurposing: Finding New Uses for Existing Medications
The field of medicine has seen an explosion of technological advancements in recent years, and artificial intelligence (AI) is at the forefront of this revolution. One of the most promising areas where AI is making a significant impact is in drug repurposing. This practice involves identifying new therapeutic applications for existing drugs, which can dramatically […]
On Demand Webinar – Data driven content – FHIR and the future of Regulatory Submissions
Overview The shift to structured content and data has been a long-term objective for regulatory agencies and the Biopharma industry. However, progress has been hampered by a lack of open and broadly adopted industry standards and tools. While the Electronic Common Technical Document (eCTD) is a widely adopted standard for regulatory submissions, it only uses […]